Clinical Trials Browser

Phase 2 × Prostatic Neoplasms × tesetaxel × Clear all

NCT01296243 2012-07-24

Tesetaxel in Chemotherapy-naive Patients With Progressive, Castration-resistant Prostate Cancer

Phase 2 Unknown

Prostatic Neoplasms